Abstract
This was a retrospective study of the effectiveness of trichosanthin (TCS), an active component isolated from the Chinese herb root tuber of Trichosanthes kirilowii on 140 cases of ectopic pregnancy with higher levels of β-human chorionic gonadotropin (β-hCG) managed with a single dose of TCS treatment. Trichosanthin has been used for medical treatment of ectopic pregnancy in China since the 1980s. This study was performed in a major teaching hospitals in China. The mean pretreatment level of β-hCG in the TCS treatment group was 3387.57 IU/L. The success rate of TCS treatment was 85% (119 of 140) which was similar to methotrexate (MTX) treatment. In 86 women with a high level of β-hCG (over 2000 IU/ L), the success rate was 80.08% when treated with TCS. Of this group, 26 women who had a high level of β-hCG (over 5000 IU/L) showed a success rate of 73%. The level of β-hCG on days 4, 7, and 10 in TCS group was significantly decreased. This study has shown that TCS may be an option for the medical treatment of unruptured ectopic pregnancy or an option for the treatment of ectopic pregnancy with higher levels of β-hCG than currently recommended for medical management with MTX.
Similar content being viewed by others
References
Anon, Ectopic pregnancies: United States, 1990–1992, MMWR Morb Mortal Wkly Rep 44. 1995, 46–48.
Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis, BMJ. 1998;316(7147):1776–1786.
RCOG. Why Mothers die 1997–1999: the Fifth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom 1997–1999. London, UK: RCOG Press; 2001.
Lipscomb GH, Stovall TG, Ling FW. Nonsurgical treatment of ectopic pregnancy. N Engl J Med. 2000;343(18):1325–1329.
American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy: the practice committee of the American society for reproductive medicine. Fertil Steril. 2006;86(6):S96–S102.
Farquhar CM. Ectopic pregnancy. Lancet. 2005;66(9485):583–591.
Stovall TG, Ling FW. Single dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol. 1993;68(6 pt 1):1759–1765.
Fylstra DL. Medical Management of Ectopic Pregnancy: ACOG Practice Bulletin no. 94. Washington, DC: American College of Obstetricians and Gynecologists; 2008.
May MJ, Hartley MR, Roberts LM, Krieg PA, Osborn RW, Lord JM. Ribosome inactivation by ricin a chain: a sensitive method to assess the activity of wild-type and mutant polypeptides. EMBO J. 1989;8(1):301–308.
Maraganore JM, Joseph M, Bailey MC. Purification and characterization of TCS. Homology to the ricin a chain and mplications as to mechanism of abortifacient activity. J Biol Chem. 1987;262(24):11628–11633.
Liu Shu-Lian, Wu Xu-Dong, Liu Guo-Wu, et al. Primary study on safety of trichosanthin combined with reserpine and testosterone propionate for termination of early & middle stage pregnancy: a clinical report of 7754 cases [In Chinese]. Reprod Contraception. 1991;11(3):46–51.
Jin YC. Crystal trichosanthin protein intramuscular or intracervical injection for the termination of pregnancy at 10 to 14 weeks gestation: clinical analysis of 200 cases [In Chinese]. Reprod Contraception. 1990;10(1):34–37.
Dai RX, Xu GJ, Lin XY, et al. Studies on injury-mechanism of trichosanthin on trophoblast cells and choriocarcinoma cells in culture [In Chinese]. Acta Biologiae Experimentalis Sinica. 1993;26(4):411–427.
Kahn JO, Kaplan LD, Gambertoglio JG, et al. The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS. 1990;4(12):1197–1204.
Mayer RA, Sergios PA, Coonan K, O’Brien L. Trichosanthin treatment of HIV-induced immune dysregulation. Eur J Clin Invest. 1992;22(2):113–122.
Byers VS, Levin AS, Waites LA, et al. A phase I/II study of trichosanthin treatment of HIV disease. AIDS. 1990;4(12):1189–1196.
Jiang HZ, Zhou ZM. Crystal trichosanthin treatment of Ectopic pregnancy: a clinnical report of 26 cases [In Chinese]. Hubei J Tradit Chin Med. 1992;14(5):7–8.
Lu PX, Jin YC. Ectopic pregnancy treated with trichosanthin. Clinical analysis of 71 patients. Chin Med J (Engl). 1989;102(5):365–367.
Egarter C, Husslein P, Yeung HW. Trichosanthin injection in tubal pregnancy. Gynecol Obstet Invest. 1991;31(2):119–120.
Stovall TG, Ling FW, Buster JE. Outpatient chemotherapy of unruptured ectopic pregnancy. Fertil Steril. 1989;51(3):435–438.
Erdem M, Erdem A, Arslan M, Oç A, Biberoğlu K, Gürsoy R. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy. Arch Gynecol Obstet. 2004;270(4):201–204.
Yao M, Tulandi T. Current status of surgical and nonsurgical management of ectopic pregnancy. Fertil Steril. 1997;67(3):421–433.
Clasen K, Camus M, Tournaye H, Devroey P. Ectopic pregnancy: let’s cut! strict laparoscopic approach to 194 consecutive cases and review of literature on alternatives. Hum Reprod. 1997;12(3):596–601.
Stika CS, Anderson L, Frederiksen MC. Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern memorial hospital three-year experience. Am J Obstet Gynecol. 1996;174(6):1840–1848.
Barnhart K, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol. 2004;104(5 pt 1):975–981.
Gabbur N, Sherer DM, Hellmann M, Abdelmalek E, Phillip P, Abulafia O. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy? Am J Perinatol. 2006;23(3):193–196.
Elson J, Tailor A, Banerjee S, Salim R, Hillaby K, Jurkovic D. Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis. Ultrasound Obstet Gynecol. 2004;23(6):552–556.
Barnhart KT, Gosman G, Ashby R. Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing ‘single dose’ and ‘multidose’ regimens. Obstet Gynecol. 2003;101(4):778–784.
Shaw PC, Lee KM, Wong KB. Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties. Toxicon. 2005;45(6):683–689.
Wang JH, Nie HL, Tarn SC, Huang H, Zheng YT. Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity. FEBS Lett. 2002;531(2):295–298.
Cheng KF. Midtrimester abortion induced by radix trichosanthis: morphologic observations in placenta and fetus. Obstet Gynecol. 1982;59(4):494–498.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xiang, D.J., Chen, L.M., Gu, J.S. et al. Trichosanthin, a Chinese Medicine for the Medical Treatment of Ectopic Pregnancy With High Levels of β-hCG. Reprod. Sci. 19, 534–538 (2012). https://doi.org/10.1177/1933719111426605
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719111426605